Multipeptide immunotherapy plus immunogenic chemotherapy in refractory cancer.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e15159
Abstract: e15159Background: Refractory tumors are a challenge. Tumor adaptive immune infiltration in several tumors, even when refractory, is not uncommon. It is clear that the future of oncology treatments ... read more here.
Keywords: immunogenic chemotherapy; immunotherapy plus; multipeptide immunotherapy; refractory ... See more keywords